Executive Director, Pharmacokinetics and Clinical Pharmacology Ionis Pharmaceuticals Carlsbad, California
Join Dan Norris and several authors in Poster Forum #7 in the Solution Center for a conversation about posters on the topic, “PKPD Modeling to Support Clinical Pharmacology”, that he is especially excited about.
M1030-10-64 Concentrations and Causal Confounding: Choosing Exposure Measures with Care When Constructing an Exposure-Response Analysis, Rena Byrne, Ph.D., Metrum Research Group
T0930-10-69 Optimizing Carvedilol Dosing Following Gastric Bypass Surgery Using Population-Based PK/PD Modeling, Priscila A. Yamamoto, MS, University of Florida
T1230-05-31 Pharmacokinetics and Interspecies Scaling of Semaglutide, a GLP-1 Receptor Agonist, Tae Suk Lee, SungKyunKwan University
M1030-10-68 Plasma Pharmacokinetics and Tissue Disposition of Cefoxitin in an Animal Model of Obesity, Yi-Hua Sheng, MS, Rutgers University
W0930-10-68 Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Pantoprazole According to CYP2C19 Genetic Polymorphism, Eunvin Ko, BS, SungKyunKwan University
T1330-03-16 pRNA Nanoparticles for Ocular Delivery: Pharmacokinetics and Pharmacodynamics After Subconjunctival Injection, Cheng Zhong, MS, University of Cincinnati